Risk of atrial fibrillation in patients with systemic sclerosis: a nationwide population-based study.

IF 4.7 2区医学 Q1 RHEUMATOLOGY Rheumatology Pub Date : 2024-10-01 DOI:10.1093/rheumatology/kead651

Oh Chan Kwon, Kyungdo Han, Min-Chan Park

{"title":"Risk of atrial fibrillation in patients with systemic sclerosis: a nationwide population-based study.","authors":"Oh Chan Kwon, Kyungdo Han, Min-Chan Park","doi":"10.1093/rheumatology/kead651","DOIUrl":null,"url":null,"abstract":"Objective: Atrial fibrillation (AF) is the most common arrhythmia in the general population, causing substantial economic burden, morbidity and mortality. The incidence rate and risk of AF in patients with SSc are unclear. We aimed to assess the incidence rate of AF in patients with SSc and the risk of incident AF in patients with SSc compared with the general population.Methods: The Korean National Health Insurance Service database was used as the data source. Patients with claims data for SSc between 2010 and 2017 were extracted from the database along with 1:5 age- and sex-matched controls. The index date was the earliest date with claims data for SSc between 2010 and 2017. The follow-up duration was from the index date to 2019. Multivariable Cox proportional hazard models were used to estimate the hazard ratio (HR) and 95% CI for AF in patients with SSc.Results: Overall, 2519 patients with SSc and 12 595 age- and sex-matched controls were included. Over a mean follow-up duration of 5.2 years (s.d. 2.6), the incidence rates of AF were 3.52 and 1.68 per 1000 person-years for patients with SSc and controls, respectively. Compared with controls, patients with SSc had a significantly higher risk of incident AF [adjusted HR 2.095 (95% CI 1.466, 2.994)].Conclusion: Patients with SSc had a 2-fold higher risk of incident AF than controls. Given the significant economic burden, morbidity and mortality that AF poses, close monitoring for incident AF in patients with SSc is warranted.","PeriodicalId":21255,"journal":{"name":"Rheumatology","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/rheumatology/kead651","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Atrial fibrillation (AF) is the most common arrhythmia in the general population, causing substantial economic burden, morbidity and mortality. The incidence rate and risk of AF in patients with SSc are unclear. We aimed to assess the incidence rate of AF in patients with SSc and the risk of incident AF in patients with SSc compared with the general population.

Methods: The Korean National Health Insurance Service database was used as the data source. Patients with claims data for SSc between 2010 and 2017 were extracted from the database along with 1:5 age- and sex-matched controls. The index date was the earliest date with claims data for SSc between 2010 and 2017. The follow-up duration was from the index date to 2019. Multivariable Cox proportional hazard models were used to estimate the hazard ratio (HR) and 95% CI for AF in patients with SSc.

Results: Overall, 2519 patients with SSc and 12 595 age- and sex-matched controls were included. Over a mean follow-up duration of 5.2 years (s.d. 2.6), the incidence rates of AF were 3.52 and 1.68 per 1000 person-years for patients with SSc and controls, respectively. Compared with controls, patients with SSc had a significantly higher risk of incident AF [adjusted HR 2.095 (95% CI 1.466, 2.994)].

Conclusion: Patients with SSc had a 2-fold higher risk of incident AF than controls. Given the significant economic burden, morbidity and mortality that AF poses, close monitoring for incident AF in patients with SSc is warranted.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

系统性硬化症患者心房颤动的风险:一项基于全国人群的研究

目的:心房颤动(AF)是普通人群中最常见的心律失常，造成了巨大的经济负担、发病率和死亡率。系统性硬化症(SSc)患者房颤的发生率和风险尚不清楚。我们的目的是评估SSc患者房颤的发生率，以及SSc患者与普通人群相比发生房颤的风险。方法:以韩国国民健康保险公团数据库为数据源。从数据库中提取2010年至2017年SSc索赔数据的患者以及1:5年龄和性别匹配的对照。指数日期是2010年至2017年期间SSc索赔数据的最早日期。随访时间为指数日至2019年。采用多变量Cox比例风险模型估计SSc患者房颤的风险比(HR)和95%置信区间(CI)。结果:总的来说，包括2519例SSc患者和12595例年龄和性别匹配的对照组。在平均5.2±2.6年的随访期间，SSc患者和对照组的房颤发病率分别为每1000人年3.52例和1.68例。与对照组相比，SSc患者发生AF的风险明显更高(调整后HR = 2.095, 95% CI = 1.466-2.994)。结论:SSc患者发生房颤的风险是对照组的两倍。鉴于房颤带来的巨大经济负担、发病率和死亡率，有必要密切监测SSc患者发生房颤的情况。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Rheumatology 医学-风湿病学

CiteScore

9.40

自引率

7.30%

发文量

1091

审稿时长

2 months

期刊介绍： Rheumatology strives to support research and discovery by publishing the highest quality original scientific papers with a focus on basic, clinical and translational research. The journal’s subject areas cover a wide range of paediatric and adult rheumatological conditions from an international perspective. It is an official journal of the British Society for Rheumatology, published by Oxford University Press. Rheumatology publishes original articles, reviews, editorials, guidelines, concise reports, meta-analyses, original case reports, clinical vignettes, letters and matters arising from published material. The journal takes pride in serving the global rheumatology community, with a focus on high societal impact in the form of podcasts, videos and extended social media presence, and utilizing metrics such as Altmetric. Keep up to date by following the journal on Twitter @RheumJnl.